Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment

Thumbnail
View/Open
Date
2021-07-19
ICR Author
Author
Pasha, N
Turner, NC
Type
Journal Article
Metadata
Show full item record
URI
https://repository.icr.ac.uk/handle/internal/4956
DOI
Collections
Subject
Science & Technology
Life Sciences & Biomedicine
Oncology
FIRST-LINE THERAPY
PHASE-III
TRASTUZUMAB EMTANSINE
POSTMENOPAUSAL WOMEN
CLONAL EVOLUTION
ESR1 MUTATIONS
DOUBLE-BLIND
INTRATUMOR HETEROGENEITY
ARTIFICIAL-INTELLIGENCE
MOLECULAR PORTRAITS
Research team
Molecular Oncology
Language
eng
Date accepted
2021-06-02
License start date
2021-07-19
Citation
NATURE CANCER, 2021, 2 (7), pp. 680 - 692 (13)
Publisher
NATURE PORTFOLIO